Company intelligence / Profile preview

Zapitall

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Zapitall is a digital health company that provides an end-to-end platform designed to streamline clinical trial recruitment and management. The company's technology focuses on increasing patient diversity and engagement through a user-friendly interface that connects patients, sites, and sponsors. By leveraging data-driven insights, Zapitall aims to accelerate the clinical development process and reduce the high costs associated with trial delays. Their services include patient screening, enrollment tracking, and retention tools tailored for the life sciences industry.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Zapitall.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zapitall.

Explore the full profile